BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32089702)

  • 21. A Case of Transudative Chylothorax: A Diagnostic Dilemma.
    Rajdev K; Avula A; Sharma D; Mansour W; Agarwal S; Siddiqui AH; Chalhoub M
    Cureus; 2018 Feb; 10(2):e2247. PubMed ID: 29719749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleural fluid analysis in chylous pleural effusion.
    Agrawal V; Doelken P; Sahn SA
    Chest; 2008 Jun; 133(6):1436-1441. PubMed ID: 18339791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleural fluid characteristics of chylothorax.
    Maldonado F; Hawkins FJ; Daniels CE; Doerr CH; Decker PA; Ryu JH
    Mayo Clin Proc; 2009 Feb; 84(2):129-33. PubMed ID: 19181646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transudative chylothorax associated with sclerosing mesenteritis.
    Rice BL; Stoller JK; Heresi GA
    Respir Care; 2010 Apr; 55(4):475-7. PubMed ID: 20406516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transjugular Intrahepatic Portosystemic Shunt (TIPS): Pathophysiologic Basics, Actual Indications and Results with Review of the Literature.
    Strunk H; Marinova M
    Rofo; 2018 Aug; 190(8):701-711. PubMed ID: 30045395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of adult idiopathic chylothorax with transudative ascites].
    Kobayashi K; Tachikawa S; Horiguchi T; Kondo R; Shiga M; Hirose M; Sasaki Y
    Nihon Kokyuki Gakkai Zasshi; 2006 Dec; 44(12):990-2. PubMed ID: 17233400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct intrahepatic portocaval shunt for refractory hepatic hydrothorax: a case report.
    Kawahara Y; Tanaka Y; Isoi N; Hatanaka K; Yamada K; Yamamoto M; Okamura T; Kaji T; Sakamoto T; Saitoh D; Ikeuchi H
    Acute Med Surg; 2017 Jul; 4(3):306-310. PubMed ID: 29123879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chylothorax with Transudate: An Unusual Presentation of Tuberculosis.
    Zamora-López MA; Farias-Navarro IC; Rendon-Ramirez EJ
    Eur J Case Rep Intern Med; 2020; 7(8):001645. PubMed ID: 32789131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thoracic duct-cutaneous fistula in a patient with cirrhosis of the liver: successful treatment with a transjugular intrahepatic portosystemic shunt.
    Rosser BG; Poterucha JJ; McKusick MA; Kamath PS
    Mayo Clin Proc; 1996 Aug; 71(8):793-6. PubMed ID: 8691901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paradigms in the management of hepatic hydrothorax: past, present, and future.
    Kumar S; Sarin SK
    Hepatol Int; 2013 Mar; 7(1):80-7. PubMed ID: 26201624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoscintigraphy findings in patients with chylothorax: influence of biochemical parameters.
    Zhang L; Zhang X; Wen Z; Tong G; Hao K; Qiu Y; Kang L
    EJNMMI Res; 2023 Aug; 13(1):72. PubMed ID: 37535169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax.
    Jeffries MA; Kazanjian S; Wilson M; Punch J; Fontana RJ
    Liver Transpl Surg; 1998 Sep; 4(5):416-23. PubMed ID: 9724480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transjugular Intrahepatic Portosystemic Shunt Occlusion Complicated with Biliary Fistula Successfully Treated with a Stent Graft: A Case Report.
    Kim E; Lee SW; Kim WH; Bae SH; Han NI; Oh JS; Chun HJ; Lee HG
    Iran J Radiol; 2016 Jan; 13(1):e28993. PubMed ID: 27127576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transudative chylothorax in liver cirrhosis; an underappreciated entity.
    Migaou A; Ben Saad A; Baili H; Mhamed SC; Achour A; Bouhlel W; Fahem N; Abdelaaly M; Rouatbi N; Joobeur S
    Respir Med Case Rep; 2020; 31():101151. PubMed ID: 32714824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chylothorax and cholesterol pleural effusion.
    Huggins JT
    Semin Respir Crit Care Med; 2010 Dec; 31(6):743-50. PubMed ID: 21213206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of refractory chylothorax with externalized pleuroperitoneal shunts in children.
    Wolff AB; Silen ML; Kokoska ER; Rodgers BM
    Ann Thorac Surg; 1999 Sep; 68(3):1053-7. PubMed ID: 10510006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large Pleural Effusion After Transjugular Intrahepatic Portosystemic Shunt, a Rare but Deadly Complication.
    Shah K; Jin MX; Bright R
    Cureus; 2021 Jul; 13(7):e16759. PubMed ID: 34513380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent chylothorax: a clinical mystery.
    Otoupalova E; Meka SG; Dogra S; Dalal B
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28988189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.